Polymer-Based Hydroxyapatite–Silver Composite Resin with Enhanced Antibacterial Activity for Dental Applications
Fecha
2024-07-15Autor
Garcia Zamarron, Diana Juana
Donohue-Cornejo, Alejandro
Cuevas-González, Juan Carlos
Espinosa Cristobal, Leon Francisco
Reyes-López, Simón Yobanny
Garibay Alvarado, Jesus Alberto
Silva Holguin, Pamela Nair
Ruiz Baltazar, Alvaro de Jesus
Metadatos
Mostrar el registro completo del ítemResumen
The primary objective of this investigation was to synthesize a resin incorporating nanoparticles
of hydroxyapatite and silver (HA-NpsAg) to enhance biocompatibility and antimicrobial efficacy,
thereby facilitating potential implementation within the dental industry. These enhancements aim
to ensure reliable, durable, functional, and aesthetically pleasing restorations while concurrently
reducing susceptibility to bacterial colonization within the oral cavity. Hydroxyapatite powders
were prepared using the sol–gel method and doped with silver nanoparticles obtained by chemical
reduction. The crystalline amorphous calcium phosphate powder had a particle size of 279 nm, and
the silver nanoparticles had an average diameter of 26.5 nm. Resin spheres containing HA-NpsAg
(RHN) were then synthesized at two concentrations (0.5% and 1%) by dissolving the initial monomer
mixture in tetrahydrofuran. Subsequent antimicrobial evaluations were conducted via agar diffusion
and turbidimetry, employing three strains of Gram-negative bacteria (E. coli, K. oxytoca, and P. aeruginosa)
and three strains of Gram-positive bacteria (S. mutans, S. aureus, and B. subtilis). The findings
revealed that P. aeruginosa exhibited maximum susceptibility to RHN powder at a concentration of
0.5%, while RHN powder at 1% concentration demonstrated maximal inhibition against S. aureus
and S. mutans. Overall, our study highlights the successful synthesis of a dental resin with hydroxyapatite
and silver nanoparticles, exhibiting bactericidal properties at low silver concentrations. These
findings hold promise for enhancing dental materials with improved antimicrobial efficacy and
clinical performance.